Libo Pharma Corp. (TPEX:7888)
Taiwan
· Delayed Price · Currency is TWD 40.90
+0.10 (0.25%)
At close: Apr 28, 2026
Libo Pharma Company Description
Libo Pharma Corp., a clinical-stage biopharmaceutical company, engage in novel therapeutics development in the field of oncology and hematology.
The company offers LIB-101, an interleukin-12 (IL-12) cytokine immunotherapy for innate immunity, adaptive immunity, and hematopoiesis.
Libo Pharma Corp. was founded in 2017 and is based in Taipei, Taiwan.
Libo Pharma Corp.
| Country | Taiwan |
| Founded | 2017 |
| Industry | Pharmaceutical Preparations |
| Employees | 31 |
Contact Details
Address: 9F - 1, No. 36, Nanjing West Road Taipei, 103614 Taiwan | |
| Website | libopharma.com |
Stock Details
| Ticker Symbol | 7888 |
| Exchange | Taipei Exchange |
| Fiscal Year | January - December |
| Reporting Currency | TWD |
| SIC Code | 2834 |